These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35792436)

  • 21. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
    Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
    J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs.
    Fukumoto S; Tamaki Y; Okamura M; Bannai H; Yokoyama N; Suzuki T; Igarashi I; Suzuki H; Xuan X
    Vaccine; 2007 Jan; 25(7):1334-41. PubMed ID: 17055131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bovine CD4(+) T-lymphocyte clones specific for rhoptry-associated protein 1 of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis.
    Brown WC; McElwain TF; Palmer GH; Chantler SE; Estes DM
    Infect Immun; 1999 Jan; 67(1):155-64. PubMed ID: 9864210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spherical Body Protein 4 from
    Mosqueda J; Hernandez-Silva DJ; Ueti MW; Cruz-Reséndiz A; Marquez-Cervantez R; Valdez-Espinoza UM; Dang-Trinh MA; Nguyen TT; Camacho-Nuez M; Mercado-Uriostegui MA; Aguilar-Tipacamú G; Ramos-Aragon JA; Hernandez-Ortiz R; Kawazu SI; Igarashi I
    Pathogens; 2023 Mar; 12(3):. PubMed ID: 36986418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RON2, a novel gene in
    Mosqueda J; Hidalgo-Ruiz M; Calvo-Olvera DA; Hernandez-Silva DJ; Ueti MW; Mercado-Uriostegui MA; Rodriguez A; Ramos-Aragon JA; Hernandez-Ortiz R; Kawazu SI; Igarashi I
    Parasitology; 2019 Nov; 146(13):1646-1654. PubMed ID: 31452491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B.
    Perdiguero B; Raman SC; Sánchez-Corzo C; Sorzano COS; Valverde JR; Esteban M; Gómez CE
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30104537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Envelope-Based Fusion Antigen GP120C14K Forming Hexamer-Like Structures Triggers T Cell and Neutralizing Antibody Responses Against HIV-1.
    Raman SC; Mejías-Pérez E; Gomez CE; García-Arriaza J; Perdiguero B; Vijayan A; Pérez-Ruiz M; Cuervo A; Santiago C; Sorzano COS; Sánchez-Corzo C; Moog C; Burger JA; Schorcht A; Sanders RW; Carrascosa JL; Esteban M
    Front Immunol; 2019; 10():2793. PubMed ID: 31867001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani.
    Guha R; Das S; Ghosh J; Naskar K; Mandala A; Sundar S; Dujardin JC; Roy S
    Vaccine; 2013 Apr; 31(15):1905-15. PubMed ID: 23499564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.
    Shephard E; Burgers WA; Van Harmelen JH; Monroe JE; Greenhalgh T; Williamson C; Williamson AL
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):207-17. PubMed ID: 18240963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenicity of
    Fernández L; Carrillo E; Sánchez-Sampedro L; Sánchez C; Ibarra-Meneses AV; Jimenez MA; Almeida VDA; Esteban M; Moreno J
    Front Immunol; 2018; 9():843. PubMed ID: 29740446
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of candidate vaccine antigens of bovine hemoparasites Theileria parva and Babesia bovis by use of helper T cell clones.
    Brown WC; Zhao S; Logan KS; Grab DJ; Rice-Ficht AC
    Vet Parasitol; 1995 Mar; 57(1-3):189-203. PubMed ID: 7597783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis.
    Pérez-Jiménez E; Kochan G; Gherardi MM; Esteban M
    Microbes Infect; 2006 Mar; 8(3):810-22. PubMed ID: 16504562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
    Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
    PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Babesia bovis RON2 contains conserved B-cell epitopes that induce an invasion-blocking humoral immune response in immunized cattle.
    Hidalgo-Ruiz M; Suarez CE; Mercado-Uriostegui MA; Hernandez-Ortiz R; Ramos JA; Galindo-Velasco E; León-Ávila G; Hernández JM; Mosqueda J
    Parasit Vectors; 2018 Nov; 11(1):575. PubMed ID: 30390674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.
    Schneider J; Langermans JA; Gilbert SC; Blanchard TJ; Twigg S; Naitza S; Hannan CM; Aidoo M; Crisanti A; Robson KJ; Smith GL; Hill AV; Thomas AW
    Vaccine; 2001 Sep; 19(32):4595-602. PubMed ID: 11535306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse.
    Guo Q; Wang L; Xu P; Geng F; Guo J; Dong L; Bao X; Zhou Y; Feng M; Wu J; Wu H; Yu B; Zhang H; Yu X; Kong W
    Oncoimmunology; 2020 Nov; 9(1):1841392. PubMed ID: 33224629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.
    Bauer A; Podola L; Mann P; Missanga M; Haule A; Sudi L; Nilsson C; Kaluwa B; Lueer C; Mwakatima M; Munseri PJ; Maboko L; Robb ML; Tovanabutra S; Kijak G; Marovich M; McCormack S; Joseph S; Lyamuya E; Wahren B; Sandström E; Biberfeld G; Hoelscher M; Bakari M; Kroidl A; Geldmacher C
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28701395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomolecular Characterization of MIC-1, a Novel Antigen in Babesia bigemina, Which Contains Conserved and Immunodominant B-Cell Epitopes that Induce Neutralizing Antibodies.
    Hernández-Silva DJ; Valdez-Espinoza UM; Mercado-Uriostegui MA; Aguilar-Tipacamú G; Ramos-Aragón JA; Hernández-Ortiz R; Ueti M; Mosqueda J
    Vet Sci; 2018 Mar; 5(2):. PubMed ID: 29570654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.